The role of АВС transporters in drug resistance to bortezomib in multiple myeloma (original) (raw)
Immunogenetic and Pharmacochemical Characterization of the Abo System Glycoprotein Properties as Criteria of Individual Sensitivity to Antitumor Agent Bortezomib in the Plasma Cell Myeloma Patients
T. Liubarets
Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology, 2019
View PDFchevron_right
Proteasome inhibitors: A rational for clinical use in the treatment of multiple myeloma
Svetislav Vrbic
Racionalna terapija
View PDFchevron_right
Serum B-cell maturation antigen (BCMA) reduces binding of anti-BCMA antibody to multiple myeloma cells
Remy Schlossberg
Leukemia research, 2019
View PDFchevron_right
[Successful use of vemurafenib in a patient with resistant hairy cell leukemia]
Любовь Аль-Ради, Andrey Sudarikov, A. Kovrigina, Larisa Kuzmina
Terapevticheskiĭ arkhiv, 2013
View PDFchevron_right
Current approaches to supportive care in multiple myeloma
Nenad Govedarovic
Srpski arhiv za celokupno lekarstvo, 2011
View PDFchevron_right
Induction therapy and the role of stem cell transplantation in the treatment of myeloma multiplex in patients aged below 65 years
Bela Balint
Srpski arhiv za celokupno lekarstvo, 2011
View PDFchevron_right
[New concept of the treatment in elderly patients with multiple myeloma]
Jelena Bila, Mirjana Gotic
Srpski arhiv za celokupno lekarstvo, 2011
View PDFchevron_right
Complex Analysis of the Role of Cytokine Gene Polymorphisms as Prognostic Factor of the Risk of Plasma Cell Myeloma in Persons Suffered After the Chornobyl NPP Accident
T. Liubarets
Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology
View PDFchevron_right
Ionizing Radiation and Cytokines: The Role in the Pathogenesis of Plasma Cell Myeloma (Literature Review)
T. Liubarets
Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology
View PDFchevron_right
Molecular Genetic Structure of Multiple Myeloma Tumour Cells Prior to Treatment and at the Time of Relapse: Short Review and Case Report
Anna Sergeeva
Russian journal of hematology and transfusiology, 2019
View PDFchevron_right
The Content of Active AKT1 Antiapoptotic Protein in Bone Marrow Cell Lyzate in Primary Myelodysplastic Syndromes
Olga Krasko
2014
View PDFchevron_right
News in the studies of multidrug resistance of breast cancer cells
Gelena Guens
Advances in molecular oncology, 2015
View PDFchevron_right
ABCA1-mediated mechanism of resistance to amphotericin B toxicity in mammalian cells
Shabaan Sayed
FEBS Open Bio, 2019
View PDFchevron_right
Recognition of the Sodium-Dependent Phosphate Transporter NaPi2b by Monoclonal Antibodies N-NaPi2b in Ovarian Cancer Cells
Natalia Akberova
Uchenye Zapiski Kazanskogo Universiteta. Seriya Estestvennye Nauki, 2020
View PDFchevron_right
The systemic factors of mitigating the contribution of the reversible phenotypic transitions of malignant cells to therapeutic resistance
Алексей Георгиевич Голубев
Voprosy Onkologii
View PDFchevron_right
Loading rate of exogenous and autoantigenic determinants on major histocompatibility complex class ii mediates resistance to multiple sclerosis
Ivan Kiselev
Доклады Академии наук, 2019
View PDFchevron_right
Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological …
Łucja Kachel
Medical Oncology, 2011
View PDFchevron_right
Vemurafenib resistant melanoma cells acquire mesenchymal stem cell-like properties
Yegor E Yegorov
Advances in molecular oncology
View PDFchevron_right
Системные факторы противодействия вкладу обратимых переходов злокачественных клеток между фенотипическими состояниями в резистентность к терапии
Alexey Golubev
Problems in oncology
View PDFchevron_right
Mechanisms of Sensitivity of Soft Tissue Sarcoma Cells to Temozolomide
Ramil Khusnutdinov
View PDFchevron_right
Frequency of coexistence and kinetics of the BCR-ABL1 transcript level and allele burden of JAK2V617F and CALR Type 1, 2 gene mutations in patients with chronic myeloid leukemia
T. Makarik
Russian journal of hematology and transfusiology, 2020
View PDFchevron_right
Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Real Life Experience
Chiara Cantò
Blood, 2018
View PDFchevron_right
ДНК-абзимы при аутоиммунной патологии в клинике и эксперименте
Sergey Suchkov
Научно-практическая ревматология, 2003
View PDFchevron_right
Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life
Elza Lomaia
Clinical oncohematology, 2017
View PDFchevron_right
GFI1b As a Novel Oncosuppressor in AML
Nasiru Aliyu
Blood, 2016
View PDFchevron_right
The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma
Helena V Zakharova
Terapevticheskii Arkhiv, 2015
View PDFchevron_right
Late myelotoxicity of high-dose chemotherapy according to the modified NHL-BFM-90 program in adult patients with diffuse large B-cell lymphoma
Sergei Kulikov
Terapevticheskii arkhiv, 2016
View PDFchevron_right
АВ0-INCOMPATIBILITY in Allogeneic Hematopoietic Stem Cell Transplantation: 15-YEARS Experience of R.M. Gorbacheva Memorial Research Institute for Children Oncology, Hematology and Transplantation
L. Zubarovskaya
Oncohematology, 2016
View PDFchevron_right
Glioblastoma: a molecular genetic portrait and modern therapeutic strategies for drug treatment
Gelena Guens
Advances in Molecular Oncology, 2021
View PDFchevron_right
Glioblastoma Multiforme: Pathogenesis and Molecular Markers
Oleg Kit
Problems in oncology, 2017
View PDFchevron_right
Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes and Clinical Significance of WT1 Gene Overexpression
Nikolay Mamaev
Clinical Oncohematology, 2014
View PDFchevron_right
Everolimus in patients with metastatic renal cell carcinoma previously treated with bevacizumab: a prospective multicenter study CRAD001LRU02T
Ashok Panneerselvam
Targeted Oncology, 2014
View PDFchevron_right
Efficiency of Bone Marrow Precursor Cell Colony-Forming as a Predictor of Disease Course in Plasma Cell Myeloma Patients with a History of Radiation Exposure
T. Liubarets
Problemy radiatsiinoi medytsyny ta radiobiolohii, 2020
View PDFchevron_right
MTR-14CELL Intrinsic Circadaian Regulation of Temozolomide Cytotoxicity in a Glioblastoma Model
jackson karanja
Neuro-Oncology, 2015
View PDFchevron_right
[Updated criteria for diagnosis and risk stratification in patients with multiple myeloma]
Jelena Bila
Srpski arhiv za celokupno lekarstvo, 2011
View PDFchevron_right